Ophthalmic aqueous composition

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10758554
APP PUB NO 20170340644A1
SERIAL NO

15523970

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

An ophthalmic aqueous composition comprises levofloxacin, a salt thereof, or a solvate thereof; dexamethasone, an ester thereof, or a salt thereof; and one or at least two isotonic agents. The ophthalmic aqueous composition is substantially free of sodium chloride. This ophthalmic aqueous composition is excellent in drug stability and drug migration and has a clear appearance.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SANTEN PHARMACEUTICAL CO LTDOSAKA JAPAN OSAKA
DAIICHI SANKYO COMPANY LIMITED3-5-1 NIHONBASHI HONCHO CHUO-KU TOKYO 103-8426

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Endo, Yoko Ikoma, JP 21 87
Takahashi, Kyohei Ikoma, JP 22 83
Umezaki, Shinya Ikoma, JP 4 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 1, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 1, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00